RG 7685

Drug Profile

RG 7685

Alternative Names: MAR 701; RG7685; RO 6807952

Latest Information Update: 19 Oct 2012

Price : $50

At a glance

  • Originator Indiana University; Marcadia Biotech
  • Developer Roche
  • Class Antihyperglycaemics; Obesity therapies; Peptides
  • Mechanism of Action Gastric inhibitory polypeptide receptor agonists; Glucagon like peptide 1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Type 2 diabetes mellitus

Most Recent Events

  • 16 Oct 2012 Discontinued - Phase-II for Type-2 diabetes mellitus in USA (SC)
  • 13 Feb 2012 Roche terminates a phase II trial in Type-2 diabetes mellitus in USA (NCT01516476)
  • 01 Nov 2011 Phase-II clinical trials in Type-2 diabetes mellitus in USA (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top